These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 1337623)
1. Lomefloxacin versus norfloxacin in the treatment of uncomplicated urinary tract infections: three-day versus seven-day treatment. The South Swedish Lolex Study Group. Neringer R; Forsgren A; Hansson C; Ode B Scand J Infect Dis; 1992; 24(6):773-80. PubMed ID: 1337623 [TBL] [Abstract][Full Text] [Related]
2. [Treatment of uncomplicated recurrent cystitis in women: lomefloxacin versus norfloxacin]. Guibert J; Herman H; Capron MH Contracept Fertil Sex; 1997 Jan; 25(1):79-84. PubMed ID: 9064058 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of lomefloxacin as compared to norfloxacin in the treatment of uncomplicated urinary tract infections in adults. Iravani A Am J Med; 1992 Apr; 92(4A):75S-81S. PubMed ID: 1316075 [TBL] [Abstract][Full Text] [Related]
4. Treatment of acute uncomplicated urinary tract infections with 3 days of lomefloxacin compared with treatment with 3 days of norfloxacin. Nicolle LE; DuBois J; Martel AY; Harding GK; Shafran SD; Conly JM Antimicrob Agents Chemother; 1993 Mar; 37(3):574-9. PubMed ID: 8384818 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of lomefloxacin versus norfloxacin in the treatment of complicated urinary tract infections. Hoepelman IM; Havinga WH; Benne RA; Zwinkels M; de Wit MA; de Hond HA; Boon TA; Visser MR; van Asbeck FW; Verhoef J Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):343-7. PubMed ID: 8394815 [TBL] [Abstract][Full Text] [Related]
6. Uncomplicated urinary tract infections: lomefloxacin versus trimethoprim/sulphamethoxazole. Guibert J; Capron MH J Int Med Res; 1992 Nov; 20(6):467-74. PubMed ID: 1337525 [TBL] [Abstract][Full Text] [Related]
7. Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women. Auquer F; Cordón F; Gorina E; Caballero JC; Adalid C; Batlle J; Clin Microbiol Infect; 2002 Jan; 8(1):50-4. PubMed ID: 11906502 [TBL] [Abstract][Full Text] [Related]
8. Single-dose compared with 3-day norfloxacin treatment of uncomplicated urinary tract infection in women. Canadian Infectious Diseases Society Clinical Trials Study Group. Saginur R; Nicolle LE Arch Intern Med; 1992 Jun; 152(6):1233-7. PubMed ID: 1599352 [TBL] [Abstract][Full Text] [Related]
9. A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections. Cox CE Am J Med; 1992 Apr; 92(4A):82S-86S. PubMed ID: 1316077 [TBL] [Abstract][Full Text] [Related]
10. Fleroxacin versus norfloxacin in the treatment of urinary tract infections: a multicenter, double-blind, prospective, randomized, comparative study. Pummer K Am J Med; 1993 Mar; 94(3A):108S-113S. PubMed ID: 8452165 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the safety and efficacy of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated urinary tract infections: results from a multicenter study. Andrade-Villanueva J; Flores-Gaxiola A; Lopez-Guillen P; Aguirre-Avalos G; Morfin-Otero R; Rodriguez-Noriega E Am J Med; 1992 Apr; 92(4A):71S-74S. PubMed ID: 1316074 [TBL] [Abstract][Full Text] [Related]
12. Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections. Naber KG; Allin DM; Clarysse L; Haworth DA; James IG; Raini C; Schneider H; Wall A; Weitz P; Hopkins G; Ankel-Fuchs D Int J Antimicrob Agents; 2004 Jun; 23(6):596-605. PubMed ID: 15194131 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of norfloxacin 800 mg once-daily versus norfloxacin 400 mg twice-daily in the treatment of uncomplicated urinary tract infections in women: a double-blind, randomized clinical trial. Pimentel FL; Dolgner A; Guimarães J; Quintas M; Mário-Reis J J Chemother; 1998 Apr; 10(2):122-7. PubMed ID: 9603637 [TBL] [Abstract][Full Text] [Related]
14. Lomefloxacin versus ciprofloxacin in the treatment of complicated urinary tract infections: a multicenter study. Pisani E; Bartoletti R; Trinchieri A; Rizzo M J Chemother; 1996 Jun; 8(3):210-3. PubMed ID: 8808718 [TBL] [Abstract][Full Text] [Related]
15. Comparison of three-day temafloxacin with seven-day ciprofloxacin treatment of urinary tract infections in women. Stein GE; Philip E J Fam Pract; 1992 Feb; 34(2):180-4. PubMed ID: 1310715 [TBL] [Abstract][Full Text] [Related]
16. [Norfloxacine efficacy in acute cystitis in the region with 10% resistance of E. coli to fluoroquinolones: a comparative randomized study]. Rafal'skiĭ VV; Malev IV; Derevitskiĭ AV; Kozlov SN; Galkin VV Urologiia; 2009; (3):18-21. PubMed ID: 19670810 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis. DeAbate CA; Bettis R; Munk ZM; Fleming H; Munn NJ; Riffer E; Bagby B; Giguere G; Collins JJ Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434 [TBL] [Abstract][Full Text] [Related]
18. Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis. Bach D; van den Berg-Segers A; Hübner A; van Breukelen G; Cesana M; Plétan Y J Urol; 1995 Jul; 154(1):19-24. PubMed ID: 7776420 [TBL] [Abstract][Full Text] [Related]
19. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected]. Iravani A; Tice AD; McCarty J; Sikes DH; Nolen T; Gallis HA; Whalen EP; Tosiello RL; Heyd A; Kowalsky SF Arch Intern Med; 1995 Mar; 155(5):485-94. PubMed ID: 7864704 [TBL] [Abstract][Full Text] [Related]
20. [A comparative study on lomefloxacin and norfloxacin in the treatment of acute uncomplicated cystitis]. Ohmori H; Kumon H; Suzuki K; Kamidono S; Arakawa S; Ishigami J; Tanaka H; Amano M; Fujita Y; Kanemasa Y Jpn J Antibiot; 1989 Apr; 42(4):1025-50. PubMed ID: 2671424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]